Your contributions help the Sentinel sustain & grow our nonprofit newsroom & bolster our commitment to delivering the important independent news our community needs to thrive
In some respects, the mechanism of GLP-1-MK-801 is similar to other therapies targeting GLP-1 receptors, in that it activates neural circuits involved in feeding, appetite, and reward
The largest real-world cohort to date, with almost 548,000 matched adults (Vidal/Akiska et al
The 8mg dose produced 21.1% average weight loss, which represents 88% of the maximum doses efficacy with meaningfully better tolerability
"I think it's helped with inflammation, and all the markers in my blood tests have been amazing the past few months
If youre thinking of switching therapies, our switching from semaglutide guide offers practical tips on making the transition smoother